Ascend Laboratories — Class II drug recall D-0547-2026
Ongoing recall by Ascend Laboratories, LLC, reported 2026-05-20, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0547-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ascend Laboratories, LLC, Bedminster, NJ, United States |
| Recall initiated | 2026-04-27 |
| Classified | 2026-05-20 |
| Reported by FDA | 2026-05-20 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 67877-0590, 67877-0590-01, 67877-0590-05, 67877-0590-10, 67877-0590-30, 67877-0590-60, 67877-0591, 67877-0591-01, 67877-0591-05, 67877-0591-10, 67877-0591-30, 67877-0591-60, 67877-0592, 67877-0592-01, 67877-0592-05, 67877-0592-10, 67877-0592-30, 67877-0592-60, 67877-0593, 67877-0593-01, 67877-0593-05, 67877-0593-10, 67877-0593-30, 67877-0593-60 |
| Lot numbers | 25140859 |
| Expiration dates | 2027-01-20 |
Product
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0547-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.